Found 12 matching trials
Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination. PHASE3 RSV (which stands for Respiratory Syncytial Virus) is an infection that cau...
Show More Location
Multiple Locations
Learn More & Join Trial
THRIVE - Trial of Passive Humoral RSV Immunity for Value and Effectiveness PHASE4 RSV is a leading cause of severe respiratory illness and hospitalisation fo...
Show More Location
Menzies School of Health Research
Learn More & Join Trial
Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India PHASE4 The purpose of this study is to describe the safety and efficacy outcomes a...
Show More Status
Active Not Recruiting
Location
Investigational Site Number : 3560002
Learn More & Join Trial
Safety of RSV Preventive Monoclonal Antibody PHASE4 This is a prospective, randomized, open-label clinical trial to evaluate th...
Show More Location
Kaiser Permanente Northern California
Learn More & Join Trial
RSV Immunisation Status in Queensland (Australia) N/A The primary objective of this study is to determine the nirsevimab immunisa...
Show More Location
Paratus Clinical Research
Learn More & Join Trial
Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection RSV in Children Under 6 Months in Bogotá N/A This study aims to evaluate the real-world effectiveness of two preventive ...
Show More Status
Active Not Recruiting
Location
Secretaria distrital de Salud
Learn More & Join Trial
The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products PHASE4 Respiratory Syncytial Virus (RSV) is the leading cause of lower respiratory...
Show More Location
Emory University School of Medicine
Learn More & Join Trial
Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China PHASE3 The purpose of this study is to evaluate the Safety and Efficacy of Nirsevi...
Show More Learn More & Join Trial
Real-World Effectiveness of Perinatal RSV Immunoprophylaxis N/A The purpose of this study is to continue evaluating how well the RSV vaccin...
Show More Location
Yale Child Health Research Center
Learn More & Join Trial
Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection N/A Respiratory syncytial virus (RSV) is a leading cause of hospitalizations fo...
Show More Status
Active Not Recruiting
Location
Griffith University
Learn More & Join Trial